Zoliflodacin Trial

Positive results announced in largest pivotal phase 3 trial of a first-in-class oral antibiotic to treat uncomplicated gonorrhoea. Our team at Wits RHI was proud to contribute to the success of this study in South Africa.
Well done to the team !!!

Prof Sinead Delany-Moretlwe, principal investigator for the trial in South Africa, said that the trial had been conducted under difficult circumstances during the height of the COVID-19 pandemic. “The huge investment in HIV trial infrastructure has really given South African scientists the capacity to do trials in infectious diseases and to yield results that can be submitted to a range of regulatory authorities”.

For more information:

Research and Policy Briefs


Stay up to date

Get updates on news, resources, events and happenings from Wits RHI.